Back to Results

Zomedica Corp (ZOMDF)

Zomedica Corp. is a healthcare company focused on veterinary health, with an emphasis on addressing unmet needs in clinical practices that serve companion animals. The company develops and commercializes diagnostic and therapeutic products, including the TRUFORMA point-of-care diagnostic platform, TRUVIEW digital cystoscopy platform, and VetGuardian remote vital-signs monitoring system. Its therapeutic portfolio also includes the PulseVet electrohydraulic shockwave therapy platform and the Assisi Loop family of devices, such as Assisi Loop, Assisi Loop Lounge, Assisi EquiLoop, and DentaLoop, which are designed to deliver targeted pulsed electromagnetic field energy for pain and inflammation management. Formerly known as Zomedica Pharmaceuticals Corp., the company adopted its current name in October 2020 and is headquartered in Ann Arbor, Michigan. Zomedica common stock trades on OTC Markets under the symbol ZOMD.F.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Next Earnings Date Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
OTC-ZOMD.F
$0.11
64.0% Upside
Bargain
Not available
Not available
Good
0.0%
November 5, 2026
0.7x
2.1x
72.712 M
36.093 M
2.3%
96.9%
-0.7
72.1%
Valuation • Fair Value

Zomedica Corp (OTC-ZOMD.F) Fair Value by Valuation Model

Review the available estimates for Zomedica Corp (OTC-ZOMD.F), including DCF Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$0.11

Estimated upside of 64.0% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

$0.15

Discounted cash flow valuation reference.

Comps Fair Value

$0.11

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 4 available valuation references for Zomedica Corp (OTC-ZOMD.F) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Zomedica Corp (OTC-ZOMD.F)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

36.877 M

Current operating scale indicator.

Revenue Forecast

45.33 M

Forward revenue estimate.

EBITDA

-13.203 M

Current operating profitability reference.

How to read profitability and growth

This section helps investors review Zomedica Corp (OTC-ZOMD.F) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Zomedica Corp (OTC-ZOMD.F)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Good

Positive financial-health read.

Piotroski Score

4

Mid-range quality score.

Beneish M-Score

-1.57

Higher caution zone on this screen.

Altman Z-Score

-0.7

Lower score that deserves closer risk review.

FCF / Net Income

72.1%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Zomedica Corp (OTC-ZOMD.F). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Zomedica Corp (OTC-ZOMD.F)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 5, 2026

Days to Earnings

44

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Zomedica Corp (OTC-ZOMD.F), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Zomedica Corp (OTC-ZOMD.F) Stock Forecast & Technical Outlook

Review Zomedica Corp (OTC-ZOMD.F) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Zomedica Corp (OTC-ZOMD.F) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Zomedica Corp (OTC-ZOMD.F) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Zomedica Corp (OTC-ZOMD.F) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Zomedica Corp (OTC-ZOMD.F) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Zomedica Corp (OTC-ZOMD.F) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Zomedica Corp (OTC-ZOMD.F)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Zomedica Corp (OTC-ZOMD.F) has a Strong Buy consensus, with 1 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 1
Hold 0
Sell 0
FAQ • Fast Investor Answers

Zomedica Corp (OTC-ZOMD.F) Stock FAQ

Data-supported answers about Zomedica Corp (OTC-ZOMD.F), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$0.11
Estimated upside 64.0%
Valuation Rating
Undervalued
Estimated upside of 64.0%
Financial Health
Good
Current financial-health read

The current fair value estimate for Zomedica Corp (OTC-ZOMD.F) is $0.11. This implies an estimated upside of 64.0% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 64.0% versus the current market price.

The current financial health read for Zomedica Corp (OTC-ZOMD.F) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Zomedica Corp (OTC-ZOMD.F) is November 5, 2026.

The latest available data indicates no current dividend yield for Zomedica Corp (OTC-ZOMD.F).

The current market capitalization listed for Zomedica Corp is 72.712 M.

The current enterprise value listed for Zomedica Corp is 36.093 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Zomedica Corp is OTC-ZOMD.F, and the stock is listed on OTC Markets.

Zomedica Corp (OTC-ZOMD.F) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Zomedica Corp is 2.3%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Zomedica Corp is 96.9%. Free float helps investors understand how much of the share base is available for public trading.

Similar Healthcare Equipment & Supplies Stocks View more on OTC Markets

Comparable companies from the same industry, limited to one security per issuer.

ABT NYSE Abbott Laboratories Fair Value Fair Market Cap 179.4 B
ISRG NASDAQ Intuitive Surgical Inc Fair Value Fair Market Cap 142 B
MDT NYSE Medtronic PLC Fair Value Fair Market Cap 116.1 B
SYK NYSE Stryker Corporation Fair Value Fair Market Cap 105.5 B
BSX NYSE Boston Scientific Corp Fair Value Undervalued Market Cap 65.099 B
EW NYSE Edwards Lifesciences Corp Fair Value Fair Market Cap 51.173 B
BDX NYSE Becton Dickinson and Co Fair Value Undervalued Market Cap 49.847 B
MDLN NASDAQ Medline Inc Fair Value Fair Market Cap 44.185 B
IDXX NASDAQ IDEXX Laboratories Inc Fair Value Fair Market Cap 41.084 B
DXCM NASDAQ DexCom Inc Fair Value Undervalued Market Cap 33.785 B
RMD NYSE ResMed Inc Fair Value Undervalued Market Cap 31.756 B
ALC NYSE Alcon AG Fair Value Undervalued Market Cap 31.674 B
GEHC NASDAQ GE HealthCare Technologies Inc Fair Value Undervalued Market Cap 29.933 B
PHG NYSE Koninklijke Philips NV ADR Fair Value Undervalued Market Cap 24.452 B
STE NYSE STERIS plc Fair Value Undervalued Market Cap 20.357 B
ZBH NYSE Zimmer Biomet Holdings Inc Fair Value Undervalued Market Cap 17.926 B
SOLV NYSE Solventum Corp Fair Value Fair Market Cap 15.107 B
PEN NYSE Penumbra Inc Fair Value Fair Market Cap 12.581 B
BAX NYSE Baxter International Inc Fair Value Fair Market Cap 12.242 B
SNN NYSE Smith & Nephew SNATS Inc Fair Value Undervalued Market Cap 11.566 B